Showing results (1951-1960 of 2,369) with videos related to
Sort By:
Pageof 237
Future Medicinal Chemistry|May 12, 2017
LTX-315: a first-in-class oncolytic peptide that reprograms the tumor microenvironmentBaldur Sveinbjørnsson, Ketil Andre Camilio, Bengt Erik Haug, et al.Future Medicinal Chemistry|May 16, 2017
Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer's diseaseDamijan Knez, Matej Sova, Urban Košak, et al.Future Medicinal Chemistry|February 4, 2010
Future of anticathepsin K drugs: dual therapy for skeletal disease and atherosclerosis?Izabela PodgorskiFuture Medicinal Chemistry|June 29, 2018
Development of a new benchmark for assessing the scoring functions applicable to protein-protein interactionsLi Han, Qifan Yang, Zhihai Liu, et al.Future Medicinal Chemistry|June 29, 2018
The current limits in virtual screening and property predictionMichael C HutterFuture Medicinal Chemistry|July 4, 2018
Design of selective histone deacetylase inhibitors: rethinking classical pharmacophoreJelena Melesina, Lucas Praetorius, Conrad V Simoben, et al.Future Medicinal Chemistry|July 6, 2018
Heptapeptide-based modification leading to enhancing the action of MTCA on activated platelets, P-selectin, GPIIb/IIIaZe Li, Fei Huang, Jianhui Wu, et al.Future Medicinal Chemistry|August 12, 2020
The roles of post-translational modifications and coactivators of STAT6 signaling in tumor growth and progressionHao Huang, Yizhou Zheng, Linfu Li, et al.Future Medicinal Chemistry|April 24, 2023
Synthetic piperidine-substituted chalcones as potential hits for α-amylase inhibitory and antioxidant activitiesIsrar Ul Haq, Irfan Ali, Uzma Salar, et al.Future Medicinal Chemistry|April 1, 2015
Nucleoside analogs and tuberculosis: new weapons against an old enemyValentina Ferrari, Michaela SerpiPageof 237